Trusted News Discovery Since 2008
{{/content}}
Novavax: Fourth Covid Vaccine Could Be Approved in the UK
Video Credit: ODN
Published on January 29, 2021 - Duration: 01:22s
Novavax: Fourth Covid Vaccine Could Be Approved in the UK
A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.
The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants.
Two vaccines have already been rolled out in the UK – from Pfizer and Oxford/AstraZeneca – while a third from Moderna has been approved for use.
The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval.
Report by Avagninag.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
You are here
💡 newsR Knowledge: Other News Mentions
South Africa
Country in Southern Africa
Steven Finn looks back on a career of touring with England, including the low of being dropped on Christmas Day and the high of taking down South Africa.
Credit: BBC Sport - Published 2 days ago
Social-networking service owned by Meta Platforms
Related videos from verified sources
Covid update: SII seeks Novavax trial approval; virus may affect sperm quality 03:20
Video credit: HT Digital Content - Published on January 29, 2021
New Covid vaccine Novavax to be assessed after successful trials 01:01
Video credit: Cover Video STUDIO - Published on January 29, 2021
Novavax COVID-19 vaccine appears 89% effective in UK study 02:06
Video credit: Euronews English - Published on January 29, 2021